source
- EGFR-Mutated NSCLC: Molecular Reassessment at Disease ProgressionIn this case-based segment, Dr. Sands presents a patient with EGFR-mutated metastatic non-small cell lung cancer who has progressed after first-line combination therapy with an EGFR tyrosine kinase…onclive · 3mo ago↗ source
- New Understandings of Treatments, End Points, and Disease Biology Expand MCL HorizonsLore Gruenbaum, PhD, discusses the direction mantle cell lymphoma is headed in addition to other critical areas of unmet needs.onclive · 3mo ago↗ source
- Cytospire hauls in $83M for a new type of T cell engagerThe British biotechnology startup is making "pan-gamma delta” T cell engagers it says can address the limitations of similar, existing therapies.BioPharma Dive